Home > New Cancer Survivor Study Shows 1/3 Battle Chronic Pain

News
New Cancer Survivor Study Shows 1/3 Battle Chronic Pain

Description

A new study shows that after surviving cancer, many people have to deal with lingering pain. Roughly one in three cancer survivors experience chronic pain, reports UPI. About one in six survivors has high impact pain that prevents them from performing everyday activities. Those numbers are twice as high compared to the general population. Chronic pain is a major side effect of cancer treatment that lingers well after therapy ends. It is associated with higher health costs and lower quality of life. Chronic pain for survivors was felt on most days or every day within the last six months. High impact chronic pain limited movement around the house or at work every day for six months or longer.

Added on the 20/06/2019 14:53:34 - Copyright : Wochit

To customise your video :

Or Create an account

More videos on the subject

  • Study Finds Minorities Underrepresented In Cancer Research

    Ethnic minorities and the elderly are underrepresented in cancer clinical trials. 83 percent of cancer trial enrollees are white (clinicaltrials.gov) African-American and Hispanic representation has actually declined since 2002. Researchers blame cultural biases and increasing healthcare costs as being major factors in the lack of representation.

    26/09/2017 - Wochit
  • New Study Shows Acupuncture May Prevent Migraines

    When most people get a headache, a simple over-the-counter pain reliever and a few moments of quiet can usually do the trick. But for millions of Americans suffering from debilitating migraines, the pain can be so intense that relief may seem out of reach. Faced with a growing demand for solutions, researchers, drug companies and medical providers have sought out new treatment options.

    21/02/2017 - Wochit
  • New Study Says Cannabis Can Treat Chronic Pain Without Addiction

    According to researchers at Oregon Health & Science University, a treatment method has been created for chronic pain using cannabis without risk of addiction. For their study, researchers used a rodent model to study the function of two types of cell membrane receptors which naturally occur in the body and bind cannabinoids. With chronic pain affecting over roughly 30 percent of the U.S. population Opioid use and addiction has run rampant in the country due to doctors over-prescribing opioid medications to treat chronic pain. Researchers add that the next step in the study is to explore brain circuitry, which could lead to a new class of pain medications.

    12/01/2017 - Wochit
  • Study Shows Keytruda Has Big Upside, Small Downside for Skin Cancer

    According to UPI, researchers claim the cancer immunotherapy drug marketed as Keytrud, was shown to have longer-lasting anti-cancer effects and fewer overall side effects than other standard treatments for advanced melanoma. In a follow-up to the phase 1 clinical trial that led to FDA approval of the drug, researchers said they saw Keytruda had greater effects with less of a downside. However, they are just analyzing the data now. The drug was approved by the FDA in 2014 for advanced melanoma treatment, but in the initial trials researchers reported effects against lung and kidney cancer, as well as fewer side effects. Former President Jimmy Carter was treated with the drug in 2015 with great success, and reported along the way that there were few side effects as he continued working during treatment. The results of the study were published in the Journal of the American Medical Association.

    23/04/2016 - Wochit
  • Faut-il renforcer la taxe Gafa ? Mounir Mahjoubi : "Pourquoi pas"

    @PascaledeLaTour : "Envisagez-vous de déposer un amendement pour renforcer l'efficacité de la taxe ?". @mounir : "Pourquoi pas mais on a voté une taxe qui va permettre de rapporter entre 400 et 600 millions, c'est déjà la moitié du chemin". #LaMatinaleLCI @LCI #La26.

    25/09/2019 - LCI